{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:24:16Z","timestamp":1762521856605},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.reuma.2015.11.002","type":"journal-article","created":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T23:46:10Z","timestamp":1451519170000},"page":"263-266","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["La acroste\u00f3lisis como indicador de gravedad en los pacientes con esclerosis sist\u00e9mica"],"prefix":"10.1016","volume":"12","author":[{"given":"Juan Carlos","family":"Arana-Ruiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Manuel","family":"Amezcua-Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2015.11.002_bib0095","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/ard.60.12.1117","article-title":"Disease severity of 100 patients with systemicsclerosis over a period of 14 years: Using a modified Medsger scale","volume":"60","author":"Geirsson","year":"2001","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2015.11.002_bib0100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.semarthrit.2007.01.005","article-title":"Update on Indices of disease activity in systemic sclerosis","volume":"37","author":"Hudson","year":"2007","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.reuma.2015.11.002_bib0105","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3899\/jrheum.091165","article-title":"Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database","volume":"37","author":"Beyer","year":"2010","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reuma.2015.11.002_bib0110","series-title":"Huesos y articulaciones en im\u00e1genes radiol\u00f3gicas","first-page":"330","article-title":"Sclerosis sist\u00e9mica progresiva","author":"Resnick","year":"2001"},{"key":"10.1016\/j.reuma.2015.11.002_bib0115","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.reuma.2012.02.006","article-title":"Raynaud, digital ulcers and calcinosis in scleroderma","volume":"8","author":"Nitsche","year":"2012","journal-title":"Reumatol Clin."},{"key":"10.1016\/j.reuma.2015.11.002_bib0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/rheumatology\/keh067","article-title":"Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis","volume":"43","author":"Mukerjee","year":"2004","journal-title":"Rheumatology."},{"key":"10.1016\/j.reuma.2015.11.002_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0300-8932(09)73130-6","article-title":"Gu\u00eda de pr\u00e1ctica cl\u00ednica para el diagn\u00f3stico y tratamiento de la hipertensi\u00f3n pulmonar","volume":"62","author":"Gali\u00e8","year":"2009","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.reuma.2015.11.002_bib0130","first-page":"42","article-title":"Assessment of disease severity and prognosis","volume":"21","author":"Medsger","year":"2003","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.reuma.2015.11.002_bib0135","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0300-8932(04)77245-0","article-title":"Gu\u00eda de pr\u00e1ctica cl\u00ednica para el diagn\u00f3stico y tratamiento de las enfermedades del pericardio. Versi\u00f3n resumida","volume":"57","author":"Maisch","year":"2004","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.reuma.2015.11.002_bib0140","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.rmed.2007.07.021","article-title":"Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease","volume":"102","author":"Zamora","year":"2008","journal-title":"Respir Med."},{"key":"10.1016\/j.reuma.2015.11.002_bib0145","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/rheumatology\/kei211","article-title":"Mycophenolate mofetil as first-line treatment improves clinically evident early sclerodermalung disease","volume":"45","author":"Liossis","year":"2006","journal-title":"Rheumatology."},{"key":"10.1016\/j.reuma.2015.11.002_bib0150","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.rmed.2010.03.018","article-title":"Therapeutic options for systemic sclerosis related interstitial lung diseases","volume":"104","author":"Mouthon","year":"2010","journal-title":"Respir Med."},{"key":"10.1016\/j.reuma.2015.11.002_bib0155","first-page":"1600","article-title":"Anti-th\/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis","volume":"33","author":"Fischer","year":"2006","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reuma.2015.11.002_bib0160","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.semarthrit.2014.09.003","article-title":"Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): Efficacy of maintenance immunosuppression in responders and non-responders","volume":"44","author":"Iudici","year":"2015","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.reuma.2015.11.002_bib0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.rdc.2013.10.001","article-title":"lmonary arterial hypertension related to connective tissue disease: A review","volume":"40","author":"Ahmed","year":"2014","journal-title":"Rheum Dis Clin N Am."},{"key":"10.1016\/j.reuma.2015.11.002_bib0170","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.autrev.2010.06.006","article-title":"Pulmonary arterial hypertension in systemic sclerosis","volume":"9","author":"Lambova","year":"2010","journal-title":"Autoimmune Rev."},{"key":"10.1016\/j.reuma.2015.11.002_bib0175","first-page":"1","article-title":"Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study","volume":"3","author":"Hsu","year":"2014","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.reuma.2015.11.002_bib0180","series-title":"Kelley's textbook of Rheumatology","first-page":"1366","author":"Boin","year":"2012"}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X15001837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X15001837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T08:50:47Z","timestamp":1537087847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X15001837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1699258X15001837"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2015.11.002","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La acroste\u00f3lisis como indicador de gravedad en los pacientes con esclerosis sist\u00e9mica","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2015.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}